RxDoctor Payments Data

Eric Pena, MD

Clinical Cardiac Electrophysiology · Medford, ORNPI 1093703563

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,592 of the $6,594 with a category attached, or 69.6%. 9 manufacturers reported payments, led by Boston Scientific at 59.4% of the total. Reporting peaked in 2023 at $2,181 and has fallen 76.2% since, to $519 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in OR, where the typical reported total is $7,720.

$6,594in general payments, 2019–2025

Across 114 payments — averaging $57.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$4K
  • Medtronic$1K
  • Biosense Webster, Inc.$804
  • Atricure, Inc.$147
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$130
  • Cordis US CORP.$119
  • plus $116 from 3 others
$103,565in research payments, 2019–2025

Across 35 payments — averaging $2959.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$57K
  • Atricure, Inc.$47K

What the payments were for

  • Travel & lodging$2,00230%
  • Food & beverage$4,59270%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,594 in reported general payments places this provider in the 40th percentile of 37 clinical cardiac electrophysiology providers in Oregon.

See all clinical cardiac electrophysiology providers in Oregon

Medicare billing

Part B allowed, 2024
$313,391
Medicare patients
877
Services billed
3,705

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban267$220,771
XareltoRivaroxaban89$97,953
JardianceEmpagliflozin14$12,786
Flecainide Acetate110$6,015
Metoprolol Succinate168$2,352
Diltiazem 24hr Er (Cd)Diltiazem Hcl45$1,300
Digoxin28$643
Amiodarone Hcl54$505
Potassium Chloride37$470
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen63$424
Carvedilol84$423
SotalolSotalol Hcl11$320
Furosemide57$278
Losartan Potassium18$160
ClopidogrelClopidogrel Bisulfate31$153

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Medford

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →